Subscribe now new to. This is g w news a line from a tourist bus hits of roadside bomb in egypt at least 17 people are injured in an explosion near the famed does appear well get the latest from our correspondent there. Indian voters reach the finish line polls close on the final day of the countrys marathon general election Prime Minister Narendra Modi is seeking a 2nd term also coming up. Austrias president calls a snap election this comes after the countrys Vice Chancellor quits following the
release of Hidden Camera video that appears to show him offering Government Contracts to a fake russian support. A Michael Okuda we begin with Breaking News in egypt where a blast has hit a bus near cairo reports say the explosion took place close to the geese at pyramids near the capital city at least 17 people were injured including foreigners most of the passengers were from south africa so far there are no reports of deaths. Lets go to journalist Ruth Michelson in cairo what more can you te
1. The 30-day composite primary safety endpoint of > 40.5% was achieved for Trilogy TAVI. 2. 8% of patients who underwent Trilogy TAVI had passed at the 1-year follow-up. Evidence Rating Level: 1 (Excellent) Study Rundown: Surgery remains the primary intervention for native aortic regurgitation, but high-risk patients lack optimal alternatives. Traditional transcatheter heart valves
A milestone has been hit at WVU Medicine Wheeling Hospital, where an innovative heart procedure was carried out for the 400th time.April 24 was the date of the
A head-to-head trial of two widely used TAVR devices in patients with small aortic annuli, mostly women, showed differences in performance at 1 year in the SMART trial.
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that the United States Food and Drug Administration (FDA) has approved the Evolut™ FX+ transcatheter aortic valve replacement (TAVR) system for the treatment of symptomatic severe aortic stenosis. The latest Evolut FX+ TAVR system maintains the valve performance benefits of the legacy Evolut TAVR platform and is designed to facilitate coronary access.